368 related articles for article (PubMed ID: 1531861)
1. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
Buscema M; Vinci C; Gatta C; Rabuazzo MA; Vignen R; Purrello F
Metabolism; 1992 Mar; 41(3):296-300. PubMed ID: 1531861
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
4. Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1 beta. Possible involvement of K+ and Ca2+ channels.
Buscema M; Rabuazzo AM; Vinci C; Caltabiano V; Vigneri R; Purrello F
Diabetologia; 1993 Sep; 36(9):791-6. PubMed ID: 8405748
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of nicotinamide-induced inhibition of poly(adenosine diphosphate-ribose) polymerase activity in rat pancreatic islets exposed to interleukin-1 beta.
Reddy S; Salari-Lak N; Sandler S
Endocrinology; 1995 May; 136(5):1907-12. PubMed ID: 7720637
[TBL] [Abstract][Full Text] [Related]
6. Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets.
Vinci C; Caltabiano V; Santoro AM; Rabuazzo AM; Buscema M; Purrello R; Rizzarelli E; Vigneri R; Purrello F
Diabetologia; 1995 Jan; 38(1):39-45. PubMed ID: 7744228
[TBL] [Abstract][Full Text] [Related]
7. Fast reversibility of glucose-induced desensitization in rat pancreatic islets. Evidence for an involvement of ionic fluxes.
Anello M; Rabuazzo AM; Degano C; Caltabiano V; Patanè G; Vigneri R; Purrello F
Diabetes; 1996 Apr; 45(4):502-6. PubMed ID: 8603773
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
10. Human interleukin-1 beta induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events.
Eizirik DL; Sandler S
Diabetologia; 1989 Nov; 32(11):769-73. PubMed ID: 2687062
[TBL] [Abstract][Full Text] [Related]
11. Not all insulin secretagogues sensitize pancreatic islets to recombinant human interleukin 1 beta.
Johannesen J; Helqvist S; Nerup J
Acta Endocrinol (Copenh); 1990 Oct; 123(4):445-52. PubMed ID: 1700570
[TBL] [Abstract][Full Text] [Related]
12. Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA.
Dunger A; Augstein P; Schmidt S; Fischer U
J Autoimmun; 1996 Jun; 9(3):309-13. PubMed ID: 8816965
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
Sandler S; Bendtzen K; Eizirik DL; Strandell E; Welsh M; Welsh N
Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical release of insulin by adult pig islets in vitro. Recovery after culture in a defined tissue culture medium.
Davalli AM; Bertuzzi F; Socci C; Scaglia L; Gavazzi F; Freschi M; DiCarlo V; Pontiroli AE; Pozza G
Transplantation; 1993 Jul; 56(1):148-54. PubMed ID: 7687394
[TBL] [Abstract][Full Text] [Related]
16. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines.
Eizirik DL; Sandler S; Welsh N; Bendtzen K; Hellerström C
Autoimmunity; 1994; 19(3):193-8. PubMed ID: 7605871
[TBL] [Abstract][Full Text] [Related]
18. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.
Comens PG; Wolf BA; Unanue ER; Lacy PE; McDaniel ML
Diabetes; 1987 Aug; 36(8):963-70. PubMed ID: 3297891
[TBL] [Abstract][Full Text] [Related]
20. Short-term exposure of rat pancreatic islets to human interleukin-1 beta increases cellular uptake of calcium.
Borg LA; Eizirik DL
Immunol Lett; 1990 Dec; 26(3):253-8. PubMed ID: 2086454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
